YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 14, 16:00
5195.85
-106.15 (-2%)
VOLUME 233,088
LIVE
NSE
May 14, 15:59
5196.85
-104.6 (-1.97%)
VOLUME 2,977,011
News on Dr Reddys Laboratories
Select Year: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Prefer HCL Tech, TCS, Tata Steel, UPL, Dabur: Joshi 

3.32 pm | 31 Dec 2013 |  Source: CNBC-TV18

Mayuresh Joshi of Angel Broking prefers HCL Technologies and Tata Consultancy Services (TCS) from the IT pack where the earnings growth both in dollar...

Dose of bitter pills, booster injections for pharma sector

1.13 pm | 29 Dec 2013 |  Source: PTI

The Indian pharma sector, estimated to be around Rs 1.5 lakh crore, recorded single digit growth for the first time in several years on account of dee...

Hold Dr Reddy's Labs, Cipla: Sudarshan Sukhani 

11.35 am | 23 Dec 2013 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one may carry positions on the long side in pharma stocks including Cipla and Dr Reddys Labor...

Dr Reddy's Labs may head higher: Sukhani 

11.18 am | 23 Dec 2013 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that Dr Reddys Laboratories may touch new life-time highs....

Bullish on Lupin, Aurobindo; cautious on Ranbaxy: Religare 

6.07 pm | 20 Dec 2013 |  Source: CNBC-TV18

Arvind Bothra, vice president of institutional research at Religare Capital Markets is cautious on Ranbaxy because the earnings visibility is very low...

Lupin, Sun Pharma, Dr Reddy's top picks: Arvind Bothra 

6.03 pm | 20 Dec 2013 |  Source: CNBC-TV18

Arvind Bothra, vice president of institutional research at Religare Capital Markets says Lupin, Sun Pharmaceutical Industries and Dr Reddy's are top p...

Pick Cipla, Dr Reddys Labs: Sriram Rathi 

1.04 pm | 20 Dec 2013 |  Source: CNBC-TV18

Sriram Rathi, pharma analyst at Anand Rathi is of the view that one may pick Cipla and Dr Reddys Laboratories from largecap pharma space....

Hold Glenmark, Cipla; prefer HCL Tech, KPIT: Deven Choksey 

12.53 pm | 20 Dec 2013 |  Source: CNBC-TV18

According to Deven Choksey, MD of KR Choksey Shares and Securities, one can prefer HCL Technologies and KPIT Technologies within the IT space and Glen...

Prefer Sun Pharma, Dr Reddy's Lab, Lupin: Dipan Mehta 

2.47 pm | 19 Dec 2013 |  Source: CNBC-TV18

Dipan Mehta, Member at BSE & NSE is of the view that one may prefer Sun Pharmaceutical Industries, Dr Reddys Laboratories and Lupin from largecap phar...

Pick Dr Reddys Laboratories: Sudarshan Sukhani 

2.42 pm | 19 Dec 2013 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one may pick Dr Reddys Laboratories and Lupin....

Super Six stocks that could do well today

8.43 am | 19 Dec 2013 |  Source: CNBC-TV18

Hemen Kapadia of KR Choksey Securities suggests buying Asian Paints with a target of Rs 505 and Dr Reddys Laboratories with a target of Rs 2493....

Prefer Dr Reddy's Labs, Aurobindo Pharma: Ajay Bodke 

11.26 am | 17 Dec 2013 |  Source: CNBC-TV18

Ajay Bodke, Head - Investment Strategy & Advisory at Prabhudas Lilladher advises to prefer Dr Reddys Laboratories, Glenmark Pharma and Aurobindo Pharm...

Prefer IT, pharma stocks: Dipan Mehta 

5.27 pm | 10 Dec 2013 |  Source: CNBC-TV18

Dipan Mehta, Member of BSE & NSE is of the view that one may prefer IT and pharma stocks....

Pharma looks attractive; prefer IT on dips: Raamdeo Agrawal 

4.01 pm | 06 Dec 2013 |  Source: CNBC-TV18

According to Raamdeo Agrawal, Joint MD at Motilal Oswal Fin Svcs, pharma sector remains a very desirable portfolio candidate....

Prefer IT, pharma stocks: Dilip Bhat 

4.16 pm | 05 Dec 2013 |  Source: CNBC-TV18

Dilip Bhat of Prabhudas Lilladher is of the view that one may prefer pharma and IT stocks....

Lupin: In capable young hands

12.01 pm | 03 Dec 2013 |  Source: Moneycontrol.com

The Lupin founder’s offspring are building a global generics powerhouse while sitting 8,000 miles apart....

Go long in JSW Steel, Dr Reddy's Labs: Ashish Chaturmohta 

3.34 pm | 27 Nov 2013 |  Source: CNBC-TV18

Ashish Chaturmohta of Fortune Equity Broker recommends going long in JSW Steel at current levels as the stock may test Rs 960-970....

Accumulate Infosys, Tech Mahindra: Nischal Maheshwari 

2.52 pm | 22 Nov 2013 |  Source: CNBC-TV18

Nischal Maheshwari of Edelweiss Financial Services is of the view that one may accumulate Infosys, Tech Mahindra and Persistent Systems from the IT sp...

Buy Sun Pharma, Cipla: Gopi Suvanam 

11.32 am | 14 Nov 2013 |  Source: CNBC-TV18

According to Gopi Suvanam, Founder of InvestWorks, one may buy Cipla and Sun Pharmaceutical Industries in the pharma space....

Go long in Dr Reddys Labs on decline: Amit Gupta 

11.03 am | 12 Nov 2013 |  Source: CNBC-TV18

Amit Gupta, Head- Derivatives at ICICI Direct recommends going long in Dr Reddys Laboratories on decline at around Rs 2430-2450 with a target of Rs 24...

1 2 3 4 5 6 7 8 9
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.